Journal
JOURNAL OF PERSONALIZED MEDICINE
Volume 13, Issue 7, Pages -Publisher
MDPI
DOI: 10.3390/jpm13071126
Keywords
GDM; diabetes; miRNA; personalized medicine
Ask authors/readers for more resources
This study conducted a systematic review to identify miRNAs associated with gestational diabetes mellitus (GDM) and build a panel of miRNAs. Fifty-five studies were included, and 82 altered miRNAs in GDM were identified, with mir-16-5p, mir-20a-5p, mir-222-3p, and mir-330-3p being the most frequently dysregulated miRNAs. Dysregulation of these miRNAs is associated with cell cycle homeostasis, growth and proliferation of pancreatic β cells, glucose uptake and metabolism, insulin secretion, and resistance.
miRNAs, a class of small non-coding RNAs, play a role in post-transcriptional gene expression. Therefore, this study aimed to conduct a systematic review of miRNAs associated with GDM to build a panel of miRNAs. A bibliographic search was carried out in the PubMed/Medline, Virtual Health Library (VHL), Web of Science, and EMBASE databases, selecting observational studies in English without time restriction. The protocol was registered on the PROSPERO platform (number CRD42021291791). Fifty-five studies were included in this systematic review, and 82 altered miRNAs in GDM were identified. In addition, four miRNAs were most frequently dysregulated in GDM (mir-16-5p, mir-20a-5p, mir-222-3p, and mir-330-3p). The dysregulation of these miRNAs is associated with the mechanisms of cell cycle homeostasis, growth, and proliferation of pancreatic & beta; cells, glucose uptake and metabolism, insulin secretion, and resistance. On the other hand, identifying miRNAs associated with GDM and elucidating its main mechanisms can assist in the characterization and definition of potential biomarkers for the diagnosis and treatment of GDM.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available